Could a cholesterol drug boost reading skills in kids with NF1?

NCT ID NCT02964884

First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This study investigates whether combining the medication lovastatin with intensive reading tutoring can improve reading abilities in children and young adults (ages 8-20) with Neurofibromatosis Type 1 (NF1) who have reading disabilities. Participants first receive either lovastatin or a placebo daily for 12 weeks, then undergo one week of specialized reading or sham tutoring. The goal is to see if the medication enhances the brain's response to tutoring by targeting a protein deficiency linked to learning and memory in NF1.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Lovastatin
What this could lead to
If it works, this could point toward a treatment that combines medication with tutoring to improve reading skills in children with NF1.
What could go wrong
This is a Phase 2 study with a small number of participants, so results may not apply to everyone. Lovastatin may cause side effects like muscle pain or digestive issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LEARNING DISABILITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Vanderbilt University

    Nashville, Tennessee, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.